Rajnish Wellness (BSE 541601)₹0.3700−2.63%Pharmaceuticals
In the Mar 2026 quarter (standalone), Rajnish Wellness reported sales of ₹102 Cr, up 1,667.0% from Mar 2025, and net profit of −₹4.71 Cr. For the year to Mar 2026, sales were ₹143 Cr and net profit −₹6.02 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.54 | 18.58 | 21.69 | 27.09 | 16.37 | 17.47 | 9.09 | 5.79 | 4.58 | 12.05 | 23.32 | 102 |
| Expenses | 8.51 | 18.51 | 21.40 | 26.51 | 16.35 | 16.98 | 8.94 | 6.40 | 4.40 | 12.25 | 24.67 | 109 |
| Operating Profit | 0.04 | 0.05 | 0.30 | 0.55 | 0.02 | 0.49 | 0.15 | −0.62 | 0.18 | −0.23 | −1.38 | −6.85 |
| OPM % | 0.4% | 0.2% | 1.4% | 2.0% | 0.1% | 2.8% | 1.6% | −10.5% | 3.8% | −1.8% | −5.9% | −6.7% |
| Other Income | 0.84 | 0.24 | 0.00 | 0.00 | 0.36 | 0.00 | 0.02 | 0.17 | 0.13 | 0.32 | 0.38 | 0.03 |
| Interest | 0.12 | 0.15 | 0.11 | 0.10 | 0.14 | 0.11 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.74 | 0.14 | 0.18 | 0.43 | 0.24 | 0.38 | 0.11 | −0.47 | 0.30 | 0.10 | −1.02 | −6.85 |
| Tax % | 24.6% | 23.1% | 35.3% | 30.9% | 26.1% | 24.3% | 20.0% | 0.0% | 27.6% | 22.2% | −9.9% | −31.2% |
| Net Profit | 0.56 | 0.11 | 0.11 | 0.29 | 0.18 | 0.29 | 0.08 | −0.47 | 0.23 | 0.07 | −0.92 | −4.71 |
| EPS (Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.02 | −0.06 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.10 | 28.11 | 42.18 | 14.04 | 13.05 | 26.10 | 26.10 | 77.30 | 49.18 | 143 | 142 |
| Expenses | 24.05 | 24.06 | 35.10 | 14.03 | 17.06 | 27.09 | 27.07 | 75.19 | 49.16 | 151 | 150 |
| Operating Profit | 1.01 | 3.01 | 7.02 | 0.00 | −3.01 | 0.00 | −1.01 | 2.01 | 0.00 | −9.01 | −8.28 |
| OPM % | 4.7% | 12.1% | 16.1% | 1.0% | −23.9% | −0.7% | −4.3% | 2.6% | 0.0% | −6.0% | −5.8% |
| Other Income | 0.00 | 1.01 | 0.00 | 0.00 | 4.02 | 1.01 | 2.01 | 0.00 | 1.01 | 1.01 | 0.86 |
| Interest | 0.00 | 1.01 | 0.99 | 1.01 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 1.01 | 4.01 | 6.02 | −1.01 | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | −8.03 | −7.47 |
| Tax % | 33.0% | 33.0% | 28.0% | −2.0% | 18.0% | 15.0% | 27.0% | 29.0% | 25.0% | −25.0% | — |
| Net Profit | 1.01 | 2.01 | 4.01 | −1.01 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | −6.02 | −5.33 |
| EPS (Rs) | 0.95 | 0.07 | 0.07 | −0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.07 | −0.08 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.04 | 2.99 | 4.99 | 4.99 | 4.99 | 10.98 | 76.99 | 76.98 | 76.95 | 102 |
| Reserves | 0.99 | 3.01 | 18.01 | 16.99 | 16.99 | 12.01 | 6.01 | 7.00 | 7.02 | 0.99 |
| Borrowings | 3.01 | 4.01 | 5.01 | 8.01 | 0.00 | 0.00 | 10.02 | 5.01 | 0.00 | 0.00 |
| Other Liabilities | 5.02 | 8.00 | 4.98 | 3.99 | 13.05 | 13.03 | 6.03 | 17.08 | 7.03 | 6.03 |
| Total Liabilities | 8.01 | 18.01 | 31.99 | 32.98 | 35.03 | 35.02 | 99.05 | 106 | 91.00 | 109 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 | 8.02 |
| Other Assets | 8.01 | 18.01 | 31.99 | 32.98 | 35.03 | 35.02 | 99.05 | 106 | 87.99 | 101 |
| Inventories | 3.51 | 2.11 | 2.93 | 1.03 | 1.09 | 2.09 | 3.74 | 9.26 | 9.86 | 13.14 |
| Trade receivables | 4.09 | 13.66 | 18.69 | 11.97 | 16.76 | 16.18 | 20.14 | 33.60 | 26.65 | 19.26 |
| Cash & equivalents | 0.18 | 0.14 | 1.56 | 0.09 | 0.19 | 0.92 | 0.35 | 0.25 | 0.41 | 9.61 |
| Total Assets | 8.01 | 18.01 | 31.99 | 32.98 | 35.03 | 35.02 | 99.05 | 106 | 91.00 | 109 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | −1.99 | −2.99 | −8.97 | −6.97 | 0.00 | −61.76 | 1.99 | −3.99 | −8.97 |
| Cash from investing activity | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.97 | −6.99 |
| Cash from financing activity | — | 0.99 | 2.99 | 9.99 | 4.99 | 0.99 | 61.92 | −1.99 | −4.99 | 24.98 |
| Net cash flow | — | 0.00 | 0.00 | 0.99 | −0.99 | 0.99 | −0.99 | 0.00 | 0.00 | 8.98 |
| Capex | 0.01 | 0.03 | 0.10 | 0.06 | 0.00 | 0.00 | 0.02 | 0.03 | 0.00 | 0.00 |
| Free cash flow | — | −2.01 | −3.01 | −9.03 | −7.02 | 0.00 | −62.19 | 2.01 | −4.02 | −9.03 |
| CFO / OP % | — | −136.0% | −90.0% | −118.0% | −4,650.0% | −32.0% | 5,577.0% | 105.0% | −41,900.0% | 94.0% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 59 | 182 | 164 | 318 | 460 | 224 | 287 | 160 | 201 | 50 |
| Inventory days | 153 | 76 | 78 | 49 | 28 | 33 | 60 | 49 | 80 | 36 |
| Days payable | 120 | 144 | 26 | 55 | 49 | 16 | 54 | 77 | 30 | 6 |
| Cash conversion cycle | 90 | 111 | 214 | 310 | 436 | 238 | 290 | 130 | 249 | 77 |
| Working capital days | 30 | 102 | 183 | 702 | 791 | 407 | 449 | 305 | 530 | 182 |
| ROCE % | — | 65.0% | 37.0% | 1.0% | 2.0% | 3.0% | 1.0% | 2.0% | 1.0% | −9.0% |
For the Mar 2026 quarter, Rajnish Wellness reported sales of ₹102 Cr, up 1,667.0% year on year and net profit of −₹4.71 Cr. The operating margin was −6.7%.
Rajnish Wellness' sales for the year to Mar 2026 were ₹143 Cr; over the last twelve months they were ₹142 Cr.
Net profit for the year to Mar 2026 was −₹6.02 Cr, and −₹5.33 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.08.
Rajnish Wellness reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹9.61 Cr.
Cash from operations was −₹8.97 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹9.03 Cr.